Lucence at #ASCO22

More Reasons to
Give Your Patients Hope

From the CEO

Friends and colleagues,

Please join us at 58th Annual ASCO Meeting from June 3-7 2022. On this page you’ll find information on our latest news, our poster presentations, and information on how to book a meeting with our team. We are at Booth #16112.

At this ASCO meeting, we’re excited to share the excellent results of extending ctRNA profiling to our ctDNA panel, and more. Our team will be present and we hope you’ll get in touch. Sign up here to make sure you receive the latest Lucence news and updates. For questions or assistance, do not hesitate to reach out to us [email protected].

We’re looking forward to seeing you in person.

Gratefully,

Min Han Tan

news-image1 news-image2

News

Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting.

Poster Presentations
and Abstracts for
#ASCO22

5 June 2022

Authors: Yukti Choudhury, Chae Yin Cher, Jiamin Ho, Claire Chan, Mun Wei Teh, Kao Chin Ngeow, Michelle Pek.

Lucence Diagnostics Pte. Ltd. (Singapore), Lucence Health (Palo Alto, CA)

Abstract #3040

Poster number: #32

5 June 2022

Authors: Yukti Choudhury, Pannapa Pinweha, Jonathan Poh, Jing Shan Lim, Min-Han Tan.

Lucence Diagnostics Pte. Ltd. (Singapore), Lucence Health (Palo Alto, CA)

Abstract #3041

Poster number: #33

5 June 2022

Authors: Jonathan Poh, Harvinder Kaur, Jia Min Ho, Yukti Choudhury, Min-Han Tan.

Lucence Diagnostics Pte. Ltd. (Singapore), 2Lucence Health Inc. (Palo Alto, CA)

Abstract #3042

Poster number: #34

Arrange a meeting with our team leadership.

-

Min-Han Tan, MBBS, PhD, FAMS CEO & Medical Director

Yukti Choudhury, PhD Chief Technology Officer

Mary Jo Mullen SVP, Commercial

Jack Challis, PhD SVP, US Operations

Jeffrey Dunklin VP, Sales

Get Updates

Sign up for the latest news and updates about Lucence at #ASCO22. For questions, email us at [email protected].